A Potential imaging agent for the GABAA receptor: 4-t-butyl-1-(4-[123I]iodophenyl)-2, 6,7-trioxabicyclo-[2.2.2]octane

Culbert, Paul A.; Chan, Swana; Wearring, Andrew V.; Chamberlain, Michael J.; Hunter, D. H.

doi:10.1016/0969-8051(93)90078-9

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Early attempts to prepare picrotoxin-like radioligands began with labeling the "cage convulsant" compound tert-butylbicycloorthobenzoate with fluorine-18 and iodine-125. Although radiochemical syntheses were successful [7][8], these radioligands showed no potential as in vivo imaging agents due to rapid hydrolysis in the blood, low brain uptake, and uniform distributions. Subsequent efforts targeted substituted 5-tert-butyl-2-phenyl-1,3dithiane derivatives and their oxides, which have demonstrated much more resistance to hydrolysis and exhibit high biological activity as insecticidal agents acting upon the GABAionophore binding site [9][10].…”

Section: Introductionmentioning

confidence: 99%

5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands

Jung

Snyder

et al. 2008

Nuclear Medicine and Biology

View full text Add to dashboard Cite

As potential new ligands targeting the binding site of gamma-aminobutyric acid (GABA) receptor ionophore, trans-5-tert-butyl-2-(4'-fluoropropynylphenyl)-2-methyl-1,1-dioxo-1,3-dithiane (1) and cis/trans-5-tert-butyl-2-(4'-fluoropropynylphenyl)-2-methyl-1,1,3,3-tetroxo-1,3-dithiane (2) were selected for radiolabeling and initial evaluation as in vivo imaging agents for positron emission tomography (PET). Both compounds exhibited identical high in vitro binding affinities (K(i)=6.5 nM). Appropriate tosylate-substituted ethynyl precursors were prepared by multistep syntheses involving stepwise sulfur oxidation and chromatographic isolation of desired trans isomers. Radiolabeling was accomplished in one step using nucleophilic [(18)F]fluorination. In vivo biodistribution studies with trans-[(18)F]1 and trans-[(18)F]2 showed significant initial uptake into mouse brain and gradual washout, with heterogeneous regional brain distributions and higher retention in the cerebral cortex and cerebellum and lower retention in the striatum and pons-medulla. These regional distributions of the new radioligands correlated with in vitro and ex vivo measures of standard radioligands binding to the ionophore- and benzodiazepine-binding sites of GABA(A) receptor in rodent brain. A comparison of these results with previously prepared radiotracers for other neurochemical targets, including successes and failures as in vivo radioligands, suggests that higher-affinity compounds with increased retention in target brain tissues will likely be needed before a successful radiopharmaceutical for human PET imaging can be identified.

show abstract

Section: Introductionmentioning

confidence: 99%